Skip to content

Stefan Ryser

President and Chief Executive Officer at Trellis Bioscience.

Earliest Form D on file: May 2026

Filed May 15, 2026

Trellis Bioscience

Biofilm-disrupting antibodies for chronic joint infections

Biotech, Redwood City CA

Signed as President and Chief Executive Officer

$6.093M

sold

Form D

LinkedIn

Network

At Trellis Bioscience

4 people